SECsense Logo

PAVmed Inc. 8-K Filing: Key Insights for Investors as of February 14, 2025

$PAVM
Form 8-K
Filed on: 2025-02-18
Source
PAVmed Inc. 8-K Filing: Key Insights for Investors as of February 14, 2025

Based on the provided XML section of the financial report, here are the key pieces of information and insights extracted:

  1. Entity Information:
  • Company Name: PAVmed Inc.
  • CIK (Central Index Key): 0001624326
  • SEC Filing Type: 8-K
  • SEC File Number: 001-37685
  • EIN (Employer Identification Number): 47-1214177
  • Address: 360 Madison Avenue, 25th Floor, New York, NY 10017
  • Phone: (917) 813-1828
  1. Filing Date:
  • The report is dated February 14, 2025.
  1. Stock Information:
  • Common Stock Par Value: $0.001 per share.
  • Ticker Symbol for Common Stock: PAVM (traded on NASDAQ).
  • Series Z Warrants to Purchase Common Stock, Ticker Symbol: PAVMZ (also traded on NASDAQ).
  1. Context Information:
  • The filing references specific periods identified as "AsOf2025-02-14" and segments for the Common Stock and Series Z Warrants, indicating the report pertains to these specific classes of stock on the specified date.
  1. Units of Measure:
  • Financial figures are reported in USD (United States Dollar) and shares.
  1. Document Structure:
  • The report utilizes XBRL (eXtensible Business Reporting Language) for financial reporting, which indicates compliance with SEC requirements for structured financial data.

Insights:

  • The filing is an 8-K, which is typically used to report unscheduled material events or corporate changes that are of importance to shareholders. Thus, it could contain critical information regarding recent developments at PAVmed Inc.
  • The specified stock par value suggests a low-cost entry point for investors, potentially indicating a strategy aimed at enhancing liquidity and accessibility for investors.
  • The presence of warrants indicates that the company may be looking to raise additional capital in the future or provide existing shareholders with the option to purchase more shares at a predetermined price.
  • The continuing trade of both common stock and warrants on NASDAQ suggests ongoing investor interest and market engagement with PAVmed Inc.

This analysis highlights the essential details investors or stakeholders would need to understand the company's current status and stock-related information as of the filing date.